Product Details
Octreotide for Injectable Suspension
Octreotide30 mg
Powder for Injectable Suspension
Vial + Diluent in Prefilled Syringe Kit
DIN/PIN/NPN
02503786
Manufacturer
Teva Canada Limited
Formulary Listing Date
2021-11-30
Unit Price
1642.1400
Amount MOH Pays
1642.1400
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
H01CB02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02239325 | Sandostatin LAR | 2189.5200 | 1642.1400 |
| 02503786 | Octreotide for Injectable Suspension | 1642.1400 | 1642.1400 |